Table 3.
Study | Lesion length, mm, mean±SD or median (IQR) | LM disease >50% | Px LAD disease % | Any LAD disease % | RCA disease % | LCX disease % | SVG disease % | Radial access % | Rotational atherectomy % | Laser atherectomy % | Scoring/cutting balloon % | Contrast volume , mL | Procedural duration , min | No. of stents , mean±SD or % | Average stent length mm | Average stent diameter |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abdelwahab et al 18 | 18 (12–23)/15 (10–20) | 1.3/1.3 | NA | 45.1/50.4 | 31.2/25.7 | 22.5/20.7 | 5.6/4.8 | NA | NA | NA | NA | NA | NA | NA | 20 (16–28)/18 (13–24) | 3 (2.8–3)/3 (2.8–3) |
Richardt et al 23 | 18.0±12.9/16.6±10.1 | 1.6/1.9 | NA | 36.7/43.9 | 34.6/28.7 | 22.9/24.0 | 3.6/1.4 | NA | NA | NA | NA | NA | NA | NA | 22.1±6.4/20.9±6.6 | 3.2±0.5/3.1±0.5 |
Gao et al 22 | 23.79±15.57/25.32±16.28 | 3.7/3.6 | NA | 40.5/43.1 | 34.0/30.8 | 20.5/22.3 | 1.3/0.3 | 70.1/80.6 | NA | NA | 3.8/1.2 | NA | NA | 2.04±1.09/1.90±1.04 (stents per patient) | 29.95±17.71/30.73±17.77 | 3.02±0.43/3.06±0.47 |
Shimonaga et al 15 | 14.6±7.0/22.0±11.7 | NA | NA | 44.1/55.2 | 32.4/24.1 | 23.5/20.7 | NA | NA | NA | NA | NA | NA | NA | 0/1.3±0.5 | 0/27.5±14.6 | 0/3.09±0.49 |
Redfors et al 19 | 27.3±20.7/27.1±20.0 | 3.3/3.8 | NA | 41.8/46.5 | 44.3/36.3 | 29.8/31.1 | 9.4/4.5 | 5.2/4.3 | NA | NA | NA | NA | NA | 1.71±1.03/1.70±1.00 | 33.1±23.5/32.4±22.2 | NA |
Buchanan et al 17 | NA | 1.8/3 | NA | 21/36 | 33/32 | 20/28 | 23/0 | NA | 1.0/4.9 | 1.6/0.3 | 19.0/5.4 | NA | NA | 1.17±0.87/1.29±0.95 | 19±6.4/19±6.7 | NA |
Lee et al 16 | 16.4±11.1/19.6±14.1 | NA | NA | 43.3/38.3 | 38.4/40.8 | 18.3/20.9 | NA | NA | NA | NA | NA | 190.3±89.2/216.2±123.6 | Fluoroscopic time 40.1±64.4/25.5±26.1 | 1.8±0.5/1.84±0.6 | 30.2±14.9/30.2±17.1 | 2.94±0.4/3.08±0.9 |
Takeuchi et al 20 | 21.8±12.2/21.5±11.9 | NA | NA | 40.4/52.0 | 36.8/27.8 | 18.2/16.4 | 0.4/0.5 | NA | 3.6/6.4 | NA | 69.6/40.9 | NA | NA | 49.3/87.9 | NA | NA |
Tamez et al 14 | 18.46±11.22/18.40±10.57 | NA | NA | NA | NA | NA | NA | NA | 0.9/1.6 | 0.5/0.1 | 17.3/3.8 | NA | NA | DES G1/G2 76 939 (90.7%), 640 432 (77.7%); and BMS G1/G2 7876 (9.3%), 184 142 (22.3%) | 19.20±7.5518.53±7.06 | 2.99±0.50 .96±0.52 |
Tang et al 12 | NA | 1.4/5.9 | NA | 39.1/44.8 | 50.7/46.8 | 26.1/26.6 | NA | 77.5/81.5 | NA | NA | NA | 239 (180, 280)/250 (200, 300) | NA | NA | NA | NA |
Wang et al 13 | 24.2±17.3/16.9±11.5 | 83.5/84.9 | NA | NA | NA | NA | 51.09±30.72/56.90±37.91 | 75.4/73.9 | 26.19±5.28/26.10±5.25 | 3.00±0.41/2.91±0.40 | ||||||
Azzalini et al 21 | Lesion length >20 mm: 68.5%/42.5% | NA | NA | 27.0/28.6 | 55.0/51.8 | 18.0/19.6 | NA | 34.2/42.7 | NA | NA | NA | 302±134/332±137 | 115±75/128±69 (min) | 2.34±1.31/2.20±1.27 (stents per patient) | 77.3±49.7/69.1±40.7 | NA |
BMS indicates bare‐metal stent; DES, drug‐eluting stent; IQR, interquartile range; LAD, left anterior descending artery; LM, left main coronary artery; NA, not applicable; Px, proximal; RCA, right coronary artery and SVG, saphenous vein graft.